Early stage drug discovery company which presents itself as working on the design of medicines with computational and artificial intelligence methods, offering drug discovery partnerships and licensing of its pipeline. Its site is still a holding page and gives no address, staff or programme detail, so nothing further about its location or projects could be confirmed.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen